These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7878966)

  • 21. Impaired B-cell tolerance in complete as compared with mixed chimeras after allogeneic bone marrow transplantation.
    Waer M; Salam A; Vandeputte M
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1281-2. PubMed ID: 8442112
    [No Abstract]   [Full Text] [Related]  

  • 22. Flt-3 ligand increases microchimerism but can prevent the therapeutic effect of donor bone marrow in transiently immunosuppressed cardiac allograft recipients.
    Antonysamy MA; Steptoe RJ; Khanna A; Rudert WA; Subbotin VM; Thomson AW
    J Immunol; 1998 Apr; 160(8):4106-13. PubMed ID: 9558122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term donor-specific tolerance in rat cardiac allografts by intrabone marrow injection of donor bone marrow cells.
    Guo K; Inaba M; Li M; An J; Cui W; Song C; Wang J; Cui Y; Sakaguchi Y; Tsuda M; Omae M; Ando Y; Li Q; Wang X; Feng W; Ikehara S
    Transplantation; 2008 Jan; 85(1):93-101. PubMed ID: 18192918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decoy against nuclear factor-kappa B attenuates myocardial cell infiltration and arterial neointimal formation in murine cardiac allografts.
    Suzuki J; Morishita R; Amano J; Kaneda Y; Isobe M
    Gene Ther; 2000 Nov; 7(21):1847-52. PubMed ID: 11110417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donor dendritic leukocytes migrate from cardiac allografts into recipients' spleens.
    Larsen CP; Morris PJ; Austyn JM
    Transplant Proc; 1990 Aug; 22(4):1943-4. PubMed ID: 2389489
    [No Abstract]   [Full Text] [Related]  

  • 27. Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation: induction of tolerance and prevention of cardiac allograft vasculopathy.
    Yamaura K; Ito K; Tsukioka K; Wada Y; Makiuchi A; Sakaguchi M; Akashima T; Fujimori M; Sawa Y; Morishita R; Matsumoto K; Nakamura T; Suzuki J; Amano J; Isobe M
    Circulation; 2004 Sep; 110(12):1650-7. PubMed ID: 15364799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of PECAM-1 in acute rejection of fully major histocompatibility complex class II-mismatched cardiac allografts in mice.
    Schramm R; Menger MD; Schmits R; Harder Y; Kirsch S; Meier C; Schäfers HJ
    Transplantation; 2007 Aug; 84(4):555-8. PubMed ID: 17713444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of chemical carcinogen-induced immunosuppression in mammary tumorigenesis in BALB-c mice.
    Medina D; Stockman G; Griswold D
    Cancer Res; 1974 Oct; 34(10):2663-8. PubMed ID: 4607071
    [No Abstract]   [Full Text] [Related]  

  • 30. Marrow graft rejection by repeated transfusions of allogeneic donor spleen cells.
    Xu LH; Fang JP; Huang WG; Xu HG; Weng WJ; Kao GS; Le Y
    Bone Marrow Transplant; 2007 Oct; 40(7):691-8. PubMed ID: 17660838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term (>1 year) analyses of chimerism and tolerance in mixed allogeneic chimeric mice using normal mouse combinations.
    Hayashi H; Toki J; Zhexiong L; Sugiura K; Inoue K; Ikehara S
    Stem Cells; 2000; 18(4):273-80. PubMed ID: 10924093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A more persistent tolerance to islet allografts through bone marrow transplantation in minimal nonmyeloablative conditioning therapy.
    Lee BW; Lee JI; Oh SH; Ahn YR; Chae HY; Lee MS; Lee MK; Kim KW
    Transplant Proc; 2005 Jun; 37(5):2266-9. PubMed ID: 15964395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Donor-specific unresponsiveness to cardiac allografts in the mouse: an examination of mechanisms.
    Bushnell A; Pearson TC; Morris PJ; Wood KJ
    Transplant Proc; 1991 Feb; 23(1 Pt 1):726-8. PubMed ID: 1990665
    [No Abstract]   [Full Text] [Related]  

  • 34. Suppression of second set rejection of skin allografts by donor bone marrow cells.
    Pourshadi M; De Fazio SR; Gozzo JJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):264. PubMed ID: 2650114
    [No Abstract]   [Full Text] [Related]  

  • 35. Cyclosporine A: graft survival and cardiotoxicity in murine cardiac allografts.
    Mirisklavos A; Mottram PL; Smith JA; Mason A; Dumble LJ; Clunie GJ; Panagiotopoulos S; Nayler WG
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1259-61. PubMed ID: 3274313
    [No Abstract]   [Full Text] [Related]  

  • 36. Cholera toxin induced tolerance to murine allografts.
    Tsugita M; Tsuru S; Taniguchi M; Shinomiya N; Ikeda M
    Transplant Proc; 1989 Feb; 21(1 Pt 1):276-7. PubMed ID: 2650118
    [No Abstract]   [Full Text] [Related]  

  • 37. Erythropoietin inhibits post-ischemic leukocyte adhesion but does not affect rejection in murine cardiac allografts.
    Schramm R; Kirsch S; Schäfers HJ; Langer F; Scheuer C; Nickels R; Harder Y; Menger MD
    J Heart Lung Transplant; 2010 Oct; 29(10):1185-92. PubMed ID: 20619682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tolerance of rat cardiac allografts does not require donor-type "passenger" antigen presenting cells.
    Popma SH; Krasinskas AM; McLean AD; Eiref SD; Moore JS; Hruban RH; Rosengard BR
    Transplant Proc; 1999; 31(1-2):840-1. PubMed ID: 10083365
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antigen- and antibody induced immunosuppression using a highly purified lipid-protein complex from mouse skin as antigen].
    Harder F; Allgöwer M; Städtler K; Schoenenberger GA
    Helv Chir Acta; 1974 Mar; 41(1-2):17-20. PubMed ID: 4611975
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of alpha-galactosylceramide upon allogenic rejection.
    Seino K; Yanagisawa K; Taniguchi H; Takada Y; Yuzawa K; Otsuka M; Fukao K
    Transplant Proc; 2001; 33(1-2):437-8. PubMed ID: 11266898
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.